Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Enveric Biosciences Inc (ENVB) vs TransMedics Group Inc (TMDX) Price & Performance

Enveric Biosciences IncTrade
TransMedics Group IncTrade

Price performance (Past 24H)

Key statistics

Enveric Biosciences Inc vs TransMedics Group Inc — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while TransMedics Group Inc trades at $89.19 (market cap $3.10B). The key difference: TransMedics Group Inc is far larger — about 500× Enveric Biosciences Inc's market cap, and TransMedics Group Inc is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.

ENVBTMDX
Market Cap
$6.20M$3.10B
Sector
HealthTechnology
52-Week High
$17.40$150.42
52-Week Low
$1.27$61.99
Enterprise Value
$1.30M$3.49B

Returns comparison

Trailing returns across standard periods

About Enveric Biosciences Inc

Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.

Read more on ENVB

About TransMedics Group Inc

TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.

Read more on TMDX